IRIS
DI MARIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.446
AS - Asia 30.861
EU - Europa 16.216
SA - Sud America 4.119
AF - Africa 1.582
Continente sconosciuto - Info sul continente non disponibili 65
OC - Oceania 61
Totale 84.350
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.628
SG - Singapore 11.846
CN - Cina 8.904
VN - Vietnam 4.337
IE - Irlanda 3.642
SE - Svezia 3.304
BR - Brasile 3.210
HK - Hong Kong 2.060
TR - Turchia 1.524
IT - Italia 1.470
DE - Germania 1.421
UA - Ucraina 1.256
FI - Finlandia 1.208
ZA - Sudafrica 1.087
NL - Olanda 966
FR - Francia 964
RU - Federazione Russa 563
GB - Regno Unito 556
CA - Canada 483
IN - India 388
AR - Argentina 332
BD - Bangladesh 248
IQ - Iraq 196
MX - Messico 188
CI - Costa d'Avorio 178
JP - Giappone 164
BE - Belgio 154
EC - Ecuador 149
ID - Indonesia 146
PL - Polonia 120
PH - Filippine 117
CO - Colombia 114
AT - Austria 109
PK - Pakistan 109
KR - Corea 99
TH - Thailandia 91
ES - Italia 86
UZ - Uzbekistan 85
VE - Venezuela 78
MA - Marocco 71
PY - Paraguay 67
CL - Cile 64
SA - Arabia Saudita 61
LT - Lituania 60
EU - Europa 59
AU - Australia 57
EG - Egitto 57
TW - Taiwan 54
RO - Romania 51
IR - Iran 49
KE - Kenya 48
AE - Emirati Arabi Uniti 45
CZ - Repubblica Ceca 44
TN - Tunisia 43
MY - Malesia 42
PE - Perù 38
IL - Israele 37
AZ - Azerbaigian 35
JO - Giordania 34
HU - Ungheria 32
UY - Uruguay 31
DZ - Algeria 30
BO - Bolivia 29
BG - Bulgaria 28
CR - Costa Rica 27
PA - Panama 26
DO - Repubblica Dominicana 23
JM - Giamaica 21
CH - Svizzera 20
NP - Nepal 20
AL - Albania 19
KG - Kirghizistan 19
PT - Portogallo 19
LB - Libano 18
SK - Slovacchia (Repubblica Slovacca) 17
OM - Oman 16
KZ - Kazakistan 15
RS - Serbia 14
HN - Honduras 12
HR - Croazia 12
SN - Senegal 12
BH - Bahrain 11
BY - Bielorussia 11
PS - Palestinian Territory 11
ET - Etiopia 10
LV - Lettonia 10
MD - Moldavia 10
TT - Trinidad e Tobago 10
GE - Georgia 9
GR - Grecia 9
SY - Repubblica araba siriana 9
DK - Danimarca 8
LK - Sri Lanka 8
LY - Libia 8
AM - Armenia 7
EE - Estonia 7
KH - Cambogia 7
KW - Kuwait 7
NG - Nigeria 7
QA - Qatar 7
Totale 84.222
Salva come PNG Salva come JPEG
Città #
Singapore 5.555
Chandler 4.808
Dublin 3.631
Ashburn 3.618
San Jose 2.448
Santa Clara 2.183
Hong Kong 1.952
Beijing 1.805
Dearborn 1.619
Ho Chi Minh City 1.405
Nanjing 1.317
Izmir 1.236
Jacksonville 1.222
Boardman 1.172
Johannesburg 1.027
Dallas 1.002
Hanoi 973
Princeton 831
Lauterbourg 721
New York 619
Shanghai 519
Los Angeles 494
Wilmington 464
San Mateo 447
Munich 435
Moscow 433
Helsinki 426
Ann Arbor 399
Shenyang 379
Nanchang 360
Columbus 325
Hebei 297
Toronto 292
São Paulo 285
Tianjin 251
Kunming 243
Jinan 227
Changsha 226
Hefei 220
Jiaxing 203
Da Nang 180
Parma 175
Haiphong 174
Kocaeli 174
Abidjan 171
Buffalo 166
Frankfurt am Main 158
Guangzhou 149
Brussels 136
Chicago 135
The Dalles 133
Norwalk 131
Seattle 125
Tokyo 124
Hangzhou 120
Tito 114
Turku 106
Zhengzhou 104
London 100
Pune 93
Fremont 92
Council Bluffs 91
Rio de Janeiro 88
Warsaw 87
Brooklyn 85
Orem 82
Milan 80
Montreal 79
Baghdad 77
Des Moines 77
Vienna 76
Atlanta 75
Houston 73
Nardò 73
Bremen 70
Denver 70
Stockholm 70
Belo Horizonte 69
Hải Dương 69
Ningbo 69
Tashkent 68
Biên Hòa 66
Nuremberg 66
Chennai 61
Phoenix 61
Genoa 58
Porto Alegre 57
Boston 56
Can Tho 56
Taranto 54
San Francisco 52
Woodbridge 51
Curitiba 49
Quito 49
Rome 49
Washington 48
Brasília 47
Campinas 45
Dhaka 45
Nairobi 44
Totale 51.471
Salva come PNG Salva come JPEG
Nome #
Associations of spink-1 (N345) and PRSS-1 (N29I AND R122H) gene mutations and chronic pancreatitis in Italy 406
5 OP Keratin 8 gene mutation in patients with chronic pancreatitis 351
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 278
Coffee intake and gastroesophageal reflux: Relationship with clinical, endoscopic and functional features 232
Studio della lattoferrina nel succo pancreatico-duodenale. Limiti nelle diagnosi di pancreatite cronica 211
Low Levels of Gastrin 17 are Related with Endoscopic Findings of Esophagitis and Typical Symptoms of GERD 197
Burning Mouth Syndrome Etiology: A Narrative Review 188
Approach to gastroenterological diseases in primary care 185
Recovery of gastric function in patients affected by chronic atrophic gastritis using L-cysteine (Acetium®): one year survey in comparison with a control group 182
Eosinophilic esophagitis in pediatric age, state of the art and review of the literature 173
Thyroid and celiac disease in pediatric age: a literature review 173
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? 170
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 166
Is it possible to withdrawal PPI’s therapy in GERD patients? A prospective study on 216 patients using HYCHSA 164
Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy 164
Endoscopic ultrasound in pediatric population: a comprehensive review of the literature 164
Long-term treatment for gastric and duodenal ulcer 163
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 162
Advanced gastric cancer: the value of surgery 161
[Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis] 159
Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against “SARS-CoV-2 Nephropathy 159
Autonomic balance in inflammatory bowel diseases, irritable bowel syndrome and gastroesophageal reflux disease 158
Association of HLA-DRB1 *0401 Allele with chronic pancreatitis 157
Barrett’s esophagus: results from an Italian cohort with tight endoscopic surveillance 157
Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases 156
CONNECTIONS BETWEEN GENETICS ANCùD CLINICAL DATA:ROLE OF MCP-1 , CFTR AND SPINK-1 IN THE CLINICAL SETTING OF ACUTE,ACUTE RECURRENT AND CHRONIC PANCREATITIS. 155
A non-invasive method for the diagnosis of upper GI diseases 155
Conservative treatment of acute appendicitis 155
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 155
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 154
H2-blockers in the treatment of ulcer disease in the elderly 154
Association of keratin 8 gene mutation with chronic pancreatitis 153
Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety 153
Growth changes after gluteen free diet in pediatric celiac patients: a literature-review 152
How and when investigating and treating Helicobacter pylori infection in children 152
7 P Frequency of CFTR gene mutations in consecutive patients suffering from chronic pancreatitis 152
Clinical markers of slow healing and relapsing gastric ulcer 152
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 152
Clinical Trends and Burden of Death in Gastric Cancer: A Six Years Survey 151
Individualized treatment of duodenal ulcer disease. A pilot study 151
[Clinical usefulness of endoscopy of the upper digestive tract in the aged] 151
Gastric function assessed by Gastropanel in very old patients (over 80 years old) and appropriateness of PPIs administration 150
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 150
Risk of tumor implantation in percutaneous endoscopic gastrostomy in the upper aerodigestive tumors 149
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. 148
Acid-related disorders in the elderly 147
Cimetidine, ranitidine, and pirenzepine in the treatment of duodenal ulcer: A six-month low-dose treatment period followed by a six-month observation period 147
Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study 147
Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact? 147
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer] 147
Gastro panel® for detection of atrophic gastritis: The “Parma model” 146
Biochemical and histopathological aspects in duodenogastric reflux gastritis patients with or without prior cholecystectomy 146
800 mg of cimetidine versus 300 mg of ranitidine at bedtime in the short-term treatment of duodenal ulcer: A cost/benefit study 146
P.08.9: The Early Diagnosis of Gastric Cancer: A Six Years Survey Based on 584 Surgical Specimen in Parma Area 146
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 146
Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients 145
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. 145
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial 145
Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status 145
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 145
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 145
S1808 Connections Between Genetics and Clinical Data: Role of MCP-1, CFTR and SPINK-1 in the Clinical Setting of Acute, Acute Recurrent and Chronic Pancreatitis 145
ACID SUPPRESSION THERAPY: WHERE DO WE FROM HERE? 144
THE SLEEPING REMNANT 144
Epidemiology and risk factors of pancreatic cancer 144
Serum pepsinogen II for early assessment of success of H. pylori eradication 144
Is the risk of contrast-induced nephropathy a real contraindication to perform intravenous contrast enhanced Computed Tomography for non-traumatic acute abdomen in Emergency Surgery Department? 144
[Clinical usefulness of the blood gastrin curve after protein meal in duodenal ulcer] 143
Comparison of 150 mg nizatidine BID or 300 mg at bedtime, and 150 mg ranitidine BID in the treatment of gastric ulcer--an 8-week randomized, double-blind multicentre study 143
Gastrin 17 in Singling Out Patients with Different Patterns of Refluxate: A Pilot Study Using Impedance-pH as Reference Standard 143
Cancer adenomas founbd during 15 years of screening in the Alto Vicentino area (north-east Italy) 143
Does chronic hypercalcemia influence serum pepsinogens levels? 142
M1695 Serum Pepsinogens and Topography of Chronic Atrophic Gastritis in a Population Sample Referred for Endoscopy 142
ASPETTI METODOLOGICI DEL SONDAGGIO GASTRICO 142
ASSESSMENT OF SYMPTOMS IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE (SUDD) 142
Epidemiology and risk factors for diverticular disease 142
Gastric and duodenal ulcer in the same patient 142
Efficacy of 5-ASA in the treatment of colonic diverticular disease 142
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status 141
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 140
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage 140
A non-invasive combined strategy to improve the appropriateness of upper gastrointestinal endoscopy 139
Bovine lactoferrin as a rescure treatment for Helicobacter pylori infection: results of a multicenter study 139
[Alcohol-dependent mast cell activation in ulcer] 139
'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection 138
A symptom-orientated PPI strategy in the treatment of the ENT manifestations of GERD. 138
[Ca 19-9 in the diagnosis of pancreatic carcinoma] 138
Microsatellite instability in colorectal cancer 138
M1261 Recurrence of Diverticulitis in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) Treated Cyclically With Mesalamine: Result of a Follow-up Study 138
P.02.5: PPI Test for Diagnosis of Body Atrophic Gastritis: A Prospective Study 138
P.154 CONNECTIONS BETWEEN GENETICS AND CLINICAL DATA: ROLE OF MCP-1, CFTR, AND SPINK-1 IN THE SETTING OF ACUTE, ACUTE RECURRENT, AND CHRONIC PANCREATITIS 137
Applications of wireless capsule endoscopy in pediatric age: an update 137
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 137
P.1.288: PEPSINOGEN I, II, RATIO, AND G-17 IN PATIENTS WITH ESOPHAGITIS AND PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD 137
Chronic atrophic gastritis (CAG) and Helicobacter pylori infection eradication: A 3 years follow-up 137
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 136
The Sleeping Remnant. Effect of Roux-En-Y Gastric Bypass on Plasma Levels of Gastric Biomarkers in Morbidly Obese Women: A Prospective Longitudinal Study 136
P.02.18: Non Invasive Diagnosis of Upper Gi Diseases in a Primary Care Setting: A Study on 1,900 Patients 136
Cure of Helicobacter pylori-positive active duodenal ulcer patients: double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy 136
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 136
Totale 15.677
Salva come PNG Salva come JPEG
Categoria #
all - tutte 296.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 296.648
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021661 0 0 0 0 0 0 0 0 0 235 372 54
2021/20223.602 47 23 52 224 206 59 213 444 176 310 342 1.506
2022/202314.711 1.540 1.337 984 1.304 1.153 1.798 103 1.127 4.622 60 555 128
2023/20244.820 251 577 136 136 414 1.364 214 351 145 282 398 552
2024/202516.639 347 988 1.140 853 1.997 1.879 504 660 2.511 1.562 1.396 2.802
2025/202630.195 3.017 3.075 3.337 2.646 4.984 2.242 3.491 962 4.228 2.213 0 0
Totale 85.085